CELLYTX

Welcome to the Brand page for “CELLYTX”, which is offered here for Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders;research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; scientific research in the field of drug discovery and development; biomedical research services; preclinical development of therapeutic products; bioinformatic services for scientific research purposes, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; scientific research, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development;.

Its status is currently believed to be active. Its class is unavailable. “CELLYTX” is believed to be currently owned by “Cellarity, Inc.”